Neonatal cancer
Neonatal cancer is rare and comprises a heterogeneous group of neoplasms with
substantial histological diversity. Almost all types of paediatric cancer can occur in fetuses …
substantial histological diversity. Almost all types of paediatric cancer can occur in fetuses …
Further delineation of the congenital form of X-linked dyskeratosis congenita (Hoyeraal-Hreidarsson syndrome)
Y Sznajer, C Baumann, A David, H Journel… - European journal of …, 2003 - Springer
Hoyeraal-Hreidarsson syndrome represents a severe variant of dyskeratosis congenita
(Zinsser-Cole-Engman syndrome). This X-linked recessive, progressive, multisystemic …
(Zinsser-Cole-Engman syndrome). This X-linked recessive, progressive, multisystemic …
Attenuation of colon inflammation through activators of the retinoid X receptor (Rxr)/Peroxisome proliferator–activated receptor Γ (Pparγ) heterodimer: A basis for new …
P Desreumaux, L Dubuquoy, S Nutten… - The Journal of …, 2001 - rupress.org
The peroxisome proliferator–activated receptor γ (PPARγ) is highly expressed in the colon
mucosa and its activation has been reported to protect against colitis. We studied the …
mucosa and its activation has been reported to protect against colitis. We studied the …
Inflammatory alterations in mesenteric adipose tissue in Crohn's disease
P Desreumaux, O Ernst, K Geboes, L Gambiez… - Gastroenterology, 1999 - Elsevier
Background & Aims: Abnormalities of fat in the mesentery including adipose tissue
hypertrophy and fat wrapping have been long recognized on surgical specimens as …
hypertrophy and fat wrapping have been long recognized on surgical specimens as …
[HTML][HTML] Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma
P Solal-Celigny, E Lepage, N Brousse… - … England Journal of …, 1993 - Mass Medical Soc
Background Interferon alfa and cytotoxic drugs have synergistic effects in patients with non-
Hodgkin's lymphoma. In 1986, we designed a clinical trial to evaluate the benefit of …
Hodgkin's lymphoma. In 1986, we designed a clinical trial to evaluate the benefit of …
[PDF][PDF] Overall genomic pattern is a predictor of outcome in neuroblastoma
I Janoueix-Lerosey, G Schleiermacher… - Journal of clinical …, 2009 - researchgate.net
Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma Page 1 Overall Genomic
Pattern Is a Predictor of Outcome in Neuroblastoma Isabelle Janoueix-Lerosey, Gudrun …
Pattern Is a Predictor of Outcome in Neuroblastoma Isabelle Janoueix-Lerosey, Gudrun …
Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and …
D Berrebi, S Bruscoli, N Cohen… - Blood, The Journal …, 2003 - ashpublications.org
Glucocorticoids and interleukin 10 (IL-10) prevent macrophage activation. In murine
lymphocytes, glucocorticoids induce expression of glucocorticoid-induced leucine zipper …
lymphocytes, glucocorticoids induce expression of glucocorticoid-induced leucine zipper …
Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular
M Peuchmaur, ESG d'Amore, VV Joshi… - … Journal of the …, 2003 - Wiley Online Library
BACKGROUND Ganglioneuroblastoma, nodular (GNBn) comprises one of the categories of
peripheral neuroblastic tumors. All tumors in this category, according to the original …
peripheral neuroblastic tumors. All tumors in this category, according to the original …
[HTML][HTML] BRAF mutation correlates with high-risk Langerhans cell histiocytosis and increased resistance to first-line therapy
S Héritier, JF Emile, MA Barkaoui… - Journal of clinical …, 2016 - ncbi.nlm.nih.gov
BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased
Resistance to First-Line Therapy - PMC Back to Top Skip to main content NIH NLM Logo Access …
Resistance to First-Line Therapy - PMC Back to Top Skip to main content NIH NLM Logo Access …
Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the β-catenin gene
S Saadi-Kheddouci, D Berrebi, B Romagnolo… - Oncogene, 2001 - nature.com
Autosomal dominant polycystic kidney disease (ADPKD) is common and is a major cause of
renal failure. Although the genetics of ADPKD are well known and have led to the discovery …
renal failure. Although the genetics of ADPKD are well known and have led to the discovery …